This Week at FDA: OST reorg correction, Califf’s supplement priorities, and more

This Week at FDA

This Week at FDAFerdous Al-Faruque • Michael Mezher

APIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy